JP2022530443A5 - - Google Patents
Info
- Publication number
- JP2022530443A5 JP2022530443A5 JP2021563172A JP2021563172A JP2022530443A5 JP 2022530443 A5 JP2022530443 A5 JP 2022530443A5 JP 2021563172 A JP2021563172 A JP 2021563172A JP 2021563172 A JP2021563172 A JP 2021563172A JP 2022530443 A5 JP2022530443 A5 JP 2022530443A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- antigen
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838286P | 2019-04-24 | 2019-04-24 | |
| US62/838,286 | 2019-04-24 | ||
| PCT/US2020/029664 WO2020219778A2 (en) | 2019-04-24 | 2020-04-23 | Anti-cd117 antibody-drug conjugates and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530443A JP2022530443A (ja) | 2022-06-29 |
| JP2022530443A5 true JP2022530443A5 (cg-RX-API-DMAC10.html) | 2022-08-23 |
Family
ID=72940692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563172A Withdrawn JP2022530443A (ja) | 2019-04-24 | 2020-04-23 | 抗cd117抗体薬物複合体およびその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220177577A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3958899A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2022530443A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020219778A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10882915B2 (en) | 2017-10-24 | 2021-01-05 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of CD117+ cells |
| WO2019217942A1 (en) | 2018-05-11 | 2019-11-14 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| CN113330026A (zh) * | 2018-10-23 | 2021-08-31 | 美真达治疗公司 | Fc沉默的抗体药物缀合物(ADC)及其用途 |
| EP3958878A4 (en) * | 2019-04-24 | 2022-12-28 | Magenta Therapeutics, Inc. | CONDITIONING METHODS FOR GENE THERAPY |
| JP2022530442A (ja) * | 2019-04-24 | 2022-06-29 | マジェンタ セラピューティクス インコーポレイテッド | アントラサイクリン抗体薬物複合体およびその使用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2613841T3 (es) * | 2008-07-16 | 2017-05-26 | Medical And Biological Laboratories Co., Ltd. | Anticuerpo anti-CLCP1 humano y uso del mismo |
| EP4063391A1 (en) * | 2012-07-25 | 2022-09-28 | Celldex Therapeutics, Inc. | Anti-kit antibodies and uses thereof |
| PT3370768T (pt) * | 2015-11-03 | 2022-04-21 | Janssen Biotech Inc | Anticorpos que se ligam especificamente ao pd-1 e seus usos |
| US10111966B2 (en) * | 2016-06-17 | 2018-10-30 | Magenta Therapeutics, Inc. | Methods for the depletion of CD117+ cells |
| EP3700568A4 (en) * | 2017-10-24 | 2021-11-10 | Magenta Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS |
| WO2019084067A1 (en) * | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | ANTI-CD117 ANTIBODIES AND METHODS OF USE |
| US10882915B2 (en) * | 2017-10-24 | 2021-01-05 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of CD117+ cells |
| JP2021526525A (ja) * | 2018-06-07 | 2021-10-07 | マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. | 抗体薬物コンジュゲート(adcs)を用いた治療方法 |
| CN113330026A (zh) * | 2018-10-23 | 2021-08-31 | 美真达治疗公司 | Fc沉默的抗体药物缀合物(ADC)及其用途 |
| AU2019374055B2 (en) * | 2018-10-30 | 2026-06-11 | Regeneron Pharmaceuticals, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
-
2020
- 2020-04-23 WO PCT/US2020/029664 patent/WO2020219778A2/en not_active Ceased
- 2020-04-23 JP JP2021563172A patent/JP2022530443A/ja not_active Withdrawn
- 2020-04-23 EP EP20794205.3A patent/EP3958899A4/en not_active Withdrawn
-
2021
- 2021-10-22 US US17/508,759 patent/US20220177577A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650819B2 (ja) | 抗-cd45抗体薬物コンジュゲート及びその使用 | |
| US20260078148A1 (en) | Amatoxin antibody-drug conjugates and uses thereof | |
| JP7709376B2 (ja) | Fcサイレンス化抗体薬物コンジュゲート(ADC)及びその使用 | |
| JP7669269B2 (ja) | 抗-cd45抗体及びそのコンジュゲート | |
| JP7280254B2 (ja) | Cd117+細胞を減少させるための組成物及び方法 | |
| TWI904109B (zh) | 抗cd45抗體及其結合物 | |
| US20220175944A1 (en) | Anti-cd117 antibody-drug conjugates and uses thereof | |
| JP2021500375A5 (cg-RX-API-DMAC10.html) | ||
| JP2021504412A (ja) | Cd5+細胞の枯渇のための組成物および方法 | |
| JP2022529726A5 (cg-RX-API-DMAC10.html) | ||
| US20220177577A1 (en) | Anti-cd117 antibody drug conjugates and uses thereof | |
| US20200376135A1 (en) | Fc silenced antibody drug conjugates (adcs) and uses thereof | |
| US20220226493A1 (en) | Anthracycline antibody-drug conjugates and uses thereof | |
| JP2022529726A (ja) | Anti-cd117とその使用 | |
| JP2025172753A (ja) | 自己免疫疾患を治療するための方法および組成物 | |
| JP2022529727A5 (cg-RX-API-DMAC10.html) | ||
| JP2022529727A (ja) | Anti-cd117 とその使用 | |
| JP2021517133A (ja) | 抗cd252抗体、コンジュゲート、および使用方法 |